The injectable excipient, which boosts the solubility of poorly soluble BCS Class II and IV APIs by up to 50,000-fold, adds to a growing track record of CPhI recognition for Lubrizol's formulation technologies
ROVIS helps pharmaceutical manufacturers to improve inspection quality, reduce false rejects and cut waste with robotics, advanced software and AI
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.